A375 cells were treated with 3 uM vemurafenib, 10 nM decitabine or the combination vemurafenib/decitabine for 72 h. At the end of the incubation, apoptosis was assessed with the Annexin V Apoptosis Detection kit (sc-4252 AK, Santa Cruz Biotechnology, Inc) according to manufacturer’s instructions. Samples were processed with the Becton Dickinson LSR II flow cytometer. Analysis was performed with FlowJo software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.